Amneal Pharmaceuticals (AMRX) EBITDA (2017 - 2026)
Amneal Pharmaceuticals (AMRX) recorded EBITDA of $152.86 million in Q3 2026, up 24.4% from $122.86 million a year earlier but down 15.8% from the prior quarter.
Amneal Pharmaceuticals (AMRX) EBITDA (2017 - 2026) Analysis & Trends
On a TTM basis, Amneal Pharmaceuticals' EBITDA came in at $688.32 million as of Sep 30, 2026, up 10.3% year-over-year; for FY2025, it came in at $640.1 million, up 24.4% from FY2024.
- Annual EBITDA has increased for three straight years, with a five-year compound annual growth rate of 13.8% (FY2020 to FY2025).
- Across earlier years, EBITDA came in at $514.61 million in FY2024 (+15.6%), $445.32 million in FY2023 (+189.5%), $153.84 million in FY2022 (-61.1%) and $395.33 million in FY2021 (+17.9%).
- Quarterly EBITDA has ranged from -$136.73 million in Q2 2022 to $188.85 million in Q1 2026 over the past five years.
- On a year-over-year basis, EBITDA rose in six of the last eight quarters, with growth averaging 45.5%.
- Peak year-over-year performance for EBITDA in the last five years was growth of 227.6% in Q1 2025, against a decline of 45.5% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $181.63 million (Q2 2026), $188.85 million (Q1 2026) and $164.98 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,305.71 Bn | 1,279.33 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 694.23 Bn | 614.09 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 528.96 Bn | 496.97 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 365.92 Bn | 328.86 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 314.95 Bn | 288.19 Bn | - | - |
| 6 | Astrazeneca | 289.15 Bn | 262.67 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 254.11 Bn | 205.76 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 211.85 Bn | 186.96 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.73 Bn | 113.09 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Amneal Pharmaceuticals | 7.21 Bn | 6.44 Bn | 334.12 Mn | 152.86 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 152.86 Mn |
| Jun 30, 2026 | 181.63 Mn |
| Mar 31, 2026 | 188.85 Mn |
| Dec 31, 2025 | 164.98 Mn |
| Sep 30, 2025 | 122.86 Mn |
| Jun 30, 2025 | 183.66 Mn |
| Mar 31, 2025 | 169.02 Mn |
| Dec 31, 2024 | 148.74 Mn |
| Sep 30, 2024 | 157.80 Mn |
| Jun 30, 2024 | 158.49 Mn |
| Mar 31, 2024 | 51.59 Mn |
| Dec 31, 2023 | 75.79 Mn |
| Sep 30, 2023 | 142.72 Mn |
| Jun 30, 2023 | 139.66 Mn |
| Mar 31, 2023 | 94.66 Mn |
| Dec 31, 2022 | 99.19 Mn |
| Sep 30, 2022 | 76.56 Mn |
| Jun 30, 2022 | -136.73 Mn |
| Mar 31, 2022 | 83.32 Mn |
| Dec 31, 2021 | 74.69 Mn |
Amneal Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();